新生學校財團法人新生醫護管理專科學校圖書館 |

Ways of regulating drugs in the 19th and 20th centuries

Record Type:	Electronic resources : Monograph/item
Title/Author:	Ways of regulating drugs in the 19th and 20th centuries/ edited by Jean-Paul Gaudillière.
other author:	Gaudillière, Jean-Paul,
Published:	Houndmills, Basingstoke, Hampshire :Palgrave Macmillan, : 2013.,
Description:	1 online resource (xiv, 327 p.) :ill. :
Subject:	Drugs - Standards. -
Online resource:	An electronic book accessible through the World Wide Web; click for information
ISBN:	9781137291523 (electronic bk.)

Ways of regulating drugs in the 19th and 20th centuries
Ways of regulating drugs in the 19th and 20th centuries[electronic resource] /edited by Jean-Paul Gaudillière. - Houndmills, Basingstoke, Hampshire :Palgrave Macmillan,2013. - 1 online resource (xiv, 327 p.) :ill. - Science, technology and medicine in modern history. - Science, technology, and medicine in modern history..

Includes bibliographical references and index.

Secrets, bureaucracy and the public: drug regulation in Prussia in the 19th century / Volker Hess -- Making Salvarsan. experimental therapy and the development and marketing of Salvarsan at the interface between science, clinic, industry and public health / Axel Hüntelmann -- Professional and industrial regulation in France and Germany: the trajectories of plant extracts / Jean-Paul Gaudillière -- Making risks visible: the science, politics and regulation of adverse drug reactions / Harry Marks -- Regulating drugs, regulating diseases: consumerism and the U.S. tolbutamide controversy / Jeremy Greene -- Thalidomide, drug safety regulation and the British Pharmaceutical Industry: the case of Imperial Chemical Industries / Viviane Quirke -- What's in a pill? on the informational enrichment of anti-cancer drugs / Alberto Cambrosio, Peter Keating, and Andrei Mogoutov -- Treating health risks or putting healthy women at risk: controversies around chemoprevention of breast cancer / Ilana Lowy -- AZT and Drug Regulatory Reform in the late Twentieth century US / Donna messner -- Professional, industrial and court regulation of drugs: the 1953 Stalinon case and Pharmaceutical Reform in postwar France / Christian Bonah -- Managing double binds in the pharmaceutical prescription market: the case of Halcion / Toine Pieters and Stephen Snelders -- Pharmaceutical patent law in-the-making: opposition and legal action by states, citizens and generics laboratories in Brazil and India / Maurice Cassier.

Among industrial goods, pharmaceuticals are those for which the concept of regulation has been most often applied. One reason for the pervasiveness of the idea of regulation is that therapeutic agents are not like other goods. Their sale and purchase constitute a very distinct market, the control and oversight of which is viewed as a means to protect public health and considered as a duty of the state since the early nineteenth century. Drug regulation thus usually focuses on actions taken by political bodies to control the technical activities of drug makers. As it developed into a large industry, drug making has become the focus of highly visible conflicts between capitalistic firms, physicians, patients, and public authorities. Other forms and targets of drug government have emerged, which not only target sales and marketing, but deal with the entire trajectory of drugs, i.e. research and development, mass production and preparation, circulation and prescription and routine clinical work. The essays assembled in this volume share the perspective that the historiography of science, technology, and medicine, therefore, needs a broader approach toward regulation; an approach taking into account the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and the means of intervention chosen in order to tame drugs in factories, offices, consulting rooms and courts. Focusing on case studies, the volume explores the 'ways of regulating drugs', which surfaced in the 19th and 20th century, and play a central role in the present world of science, market and medicine.

ISBN: 9781137291523 (electronic bk.)

Source: 513403Palgrave Macmillanhttp://www.palgraveconnect.comSubjects--Topical Terms:

238376
Drugs
--Standards.Index Terms--Genre/Form:

96803
Electronic books.

LC Class. No.: RS189 / .W39 2013

Dewey Class. No.: 338.4/76151

National Library of Medicine Call No.: 2013 A-762

Ways of regulating drugs in the 19th and 20th centuries
LDR:04401cmm a2200337Ka 4500 001 132032
003 OCoLC
005 20130621115217.0
006 m o d
007 cr cn|||||||||
008 160105s2013 enka ob 001 0 eng d
020 $a 9781137291523 (electronic bk.)
020 $a 1137291524 (electronic bk.)
035 $a (OCoLC)831628022
035 $a ocn831628022
037 $a 513403 $b Palgrave Macmillan $n http://www.palgraveconnect.com
040 $a UKPGM $b eng $c UKPGM $d OCLCO
049 $a TEFA
050 4 $a RS189 $b .W39 2013
060 1 4 $a 2013 A-762
060 1 4 $a QV 11.1
082 0 4 $a 338.4/76151 $2 23
245 0 0 $a Ways of regulating drugs in the 19th and 20th centuries $h [electronic resource] / $c edited by Jean-Paul Gaudillière.
260 $a Houndmills, Basingstoke, Hampshire : $c 2013. $b Palgrave Macmillan,
300 $a 1 online resource (xiv, 327 p.) : $b ill.
490 1 $a Science, technology and medicine in modern history
504 $a Includes bibliographical references and index.
505 0 $a Secrets, bureaucracy and the public: drug regulation in Prussia in the 19th century / Volker Hess -- Making Salvarsan. experimental therapy and the development and marketing of Salvarsan at the interface between science, clinic, industry and public health / Axel Hüntelmann -- Professional and industrial regulation in France and Germany: the trajectories of plant extracts / Jean-Paul Gaudillière -- Making risks visible: the science, politics and regulation of adverse drug reactions / Harry Marks -- Regulating drugs, regulating diseases: consumerism and the U.S. tolbutamide controversy / Jeremy Greene -- Thalidomide, drug safety regulation and the British Pharmaceutical Industry: the case of Imperial Chemical Industries / Viviane Quirke -- What's in a pill? on the informational enrichment of anti-cancer drugs / Alberto Cambrosio, Peter Keating, and Andrei Mogoutov -- Treating health risks or putting healthy women at risk: controversies around chemoprevention of breast cancer / Ilana Lowy -- AZT and Drug Regulatory Reform in the late Twentieth century US / Donna messner -- Professional, industrial and court regulation of drugs: the 1953 Stalinon case and Pharmaceutical Reform in postwar France / Christian Bonah -- Managing double binds in the pharmaceutical prescription market: the case of Halcion / Toine Pieters and Stephen Snelders -- Pharmaceutical patent law in-the-making: opposition and legal action by states, citizens and generics laboratories in Brazil and India / Maurice Cassier.
520 $a Among industrial goods, pharmaceuticals are those for which the concept of regulation has been most often applied. One reason for the pervasiveness of the idea of regulation is that therapeutic agents are not like other goods. Their sale and purchase constitute a very distinct market, the control and oversight of which is viewed as a means to protect public health and considered as a duty of the state since the early nineteenth century. Drug regulation thus usually focuses on actions taken by political bodies to control the technical activities of drug makers. As it developed into a large industry, drug making has become the focus of highly visible conflicts between capitalistic firms, physicians, patients, and public authorities. Other forms and targets of drug government have emerged, which not only target sales and marketing, but deal with the entire trajectory of drugs, i.e. research and development, mass production and preparation, circulation and prescription and routine clinical work. The essays assembled in this volume share the perspective that the historiography of science, technology, and medicine, therefore, needs a broader approach toward regulation; an approach taking into account the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and the means of intervention chosen in order to tame drugs in factories, offices, consulting rooms and courts. Focusing on case studies, the volume explores the 'ways of regulating drugs', which surfaced in the 19th and 20th century, and play a central role in the present world of science, market and medicine.
588 $a Description based on print version record.
650 0 $a Drugs $x Standards. $3 238376
650 0 $a Pharmaceutical industry $x Quality control. $3 200132
650 0 $a Drugs $x Law and legislation $x History $y 19th century. $3 238377
650 0 $a Drugs $x Law and legislation $x History $y 20th century. $3 238378
650 1 2 $a Drug Industry $x standards. $3 200970
650 1 2 $a Drug and Narcotic Control $x history. $3 238379
650 2 2 $a History, 19th Century. $3 205386
650 2 2 $a History, 20th Century. $3 205385
650 2 2 $a Legislation, Pharmacy $x history. $3 238380
650 2 2 $a Pharmaceutical Preparations $x standards. $3 238381
650 2 2 $a Quality Control. $3 82033
655 7 $a Electronic books. $2 local. $3 96803
700 1 $a Gaudillière, Jean-Paul, $d 1957- $3 238374
700 1 $a Hess, Volker. $3 238375
710 2 $a Palgrave Connect (Online service) $3 227469
776 $t Ways of regulating drugs in the 19th and 20th centuries $6 132032
830 0 $a Science, technology, and medicine in modern history. $3 235335
856 4 0 $3 Palgrave Connect $u http://www.palgraveconnect.com/doifinder/10.1057/9781137291523 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF